HIVandHepatitis.com

Home
HIVandHepatitis.com

Latest news about HIV, hepatitis B, and hepatitis C, including medical journal summaries and conference coverage

24/09/2018

Good news for people with hep C...

--(BUSINESS WIRE)--Sep. 24, 2018-- (NASDAQ: GILD) announced today plans to launch authorized generic versions of Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni® (ledipasvir 90mg/sofosbuvir 400mg), Gilead’s leading treatments for chronic hepatitis C virus (HCV), in , through a newly cr...

06/09/2018

The latest San Francisco HIV Epidemiology Report is out. New HIV infections continue to decline, but not as steeply. PrEP and rapid treatment as prevention ("undetectable = untransmittable") are working. Efforts now need to focus on those who haven't been reached -- black gay and bi men, people who inject drugs and especially homeless people (though interestingly, it looks like efforts to reach trans women have been successful).

The latest San Francisco HIV epidemiology report shows that while the number of new infections continues to decline, African-Americans and homeless people have persistently higher infection rates and poorer outcomes.

23/07/2018

tribute to colleagues lost in MH17 airliner attack en route to AIDS 2014 in Melbourne

12/04/2018

Covering International Liver Congress this week in Paris

05/03/2018

First report from . Follow live tweets via

Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston...

03/03/2018

Needless to say if you know me, I’m very pleased with this year’s color scheme. Follow conference tweets via starting Sunday.

02/02/2018

February 1, 2018 – Treatment Action Group has just released an updated Training Manual for Treatment Activists: Hepatitis C and HIV Coinfection.

14/01/2018

Please check out Cancer Health -- and like on Facebook and follow on Twitter in interested!

30/12/2017

HIVandHepatitis.com will be no longer publish new content, but will stay around as an archive under the auspices of Smart and Strong. on Twitter will become .